These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1975281)

  • 21. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of beta-adrenoblockers in the treatment of acute myocardial infarct patients].
    Ol'binskaia LI; Maglakelidze TA; Cherniak MS
    Klin Med (Mosk); 1987 Feb; 65(2):35-8. PubMed ID: 2883341
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.
    Viskin S; Kitzis I; Lev E; Zak Z; Heller K; Villa Y; Zajarias A; Laniado S; Belhassen B
    J Am Coll Cardiol; 1995 May; 25(6):1327-32. PubMed ID: 7722129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of beta blockers on the parameters of acute phase response and level of circulating immune complexes in myocardial infarct].
    Korochkin IM; Chukaeva II; Aleshkin AV; Smolina NV; Litvinova SN; Aleksandrov AA
    Sov Med; 1991; (6):45-7. PubMed ID: 1716007
    [No Abstract]   [Full Text] [Related]  

  • 25. [Regulation of beta receptors--practical consequences for therapy].
    Reithmann C; Werdan K
    Internist (Berl); 1990 Oct; 31(10):625-31. PubMed ID: 1980913
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic potential of beta-receptor blockers in acute anterior wall infarct].
    Jentsch G
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):543-4. PubMed ID: 6124886
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
    Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of obzidan on cell membrane permeability in myocardial infarct patients].
    Parkhomenko AN; Netiazhenko VZ; Angelutsa PA
    Vrach Delo; 1985 Aug; (8):16-9. PubMed ID: 4072104
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta blockage after myocardial infarct].
    Frick MH; Katila M
    Duodecim; 1982; 98(2):150-7. PubMed ID: 6120827
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of dl-demethyl coclaurine on beta-adrenergic receptors and adenylate cyclase in turkey erythrocyte membrane].
    Feng YP; Jia HJ; Zhang LY; Zeng GY
    Yao Xue Xue Bao; 1982 Sep; 17(9):641-6. PubMed ID: 6130668
    [No Abstract]   [Full Text] [Related]  

  • 33. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction.
    Rochon PA; Tu JV; Anderson GM; Gurwitz JH; Clark JP; Lau P; Szalai JP; Sykora K; Naylor CD
    Lancet; 2000 Aug; 356(9230):639-44. PubMed ID: 10968437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta receptor blocker in acute myocardial infarct and in secondary prevention].
    Werdan K
    Internist (Berl); 1991 May; 32(5):300-1. PubMed ID: 1678386
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and beta 1-, beta 2-adrenergic receptor binding studies of 4-acylamino-substituted phenoxypropanolamine and 5-acylamino-substituted naphthyloxypropanolamine derivatives.
    Jindal DP; Coumar MS; Bruni G; Massarelli P
    Arzneimittelforschung; 2002; 52(9):654-63. PubMed ID: 12404879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pulmonary hemodynamics following experimental myocardial ischemia after the blockade of adrenergic receptors].
    Evlakhov VI; Poiasov IZ
    Ross Fiziol Zh Im I M Sechenova; 2015 Jan; 101(1):44-53. PubMed ID: 25868325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CLINICAL PERSPECTIVES OF COMPLEX APPLICATION OF PERCUTANEOUS CORONARY INTERVENTION AND DRUG REVASCULARIZATION IN ACUTE CORONARY SYNDROME].
    Agayev MM
    Lik Sprava; 2014; (9-10):46-56. PubMed ID: 26492775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.